Tamoxifen, Nolvadex

Tamoxifen, Nolvadex CAS: 10540-29-1 MF: C26H29NO MW: 371.51 EINECS: 234-118-0

Chemical Properties White Crystalline Solid mp 97-98 °C(lit.) storage temp. 2-8°C Usage A nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer.

Tamoxifen is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor.

Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is dependent upon PAX2. Blocks estradiol-stimulated VEGF production in breast tumor cells. Protein kinase C inhibitor.

Induces apoptosis in human malignant glioma cell lines. Tamoxifen and its metabolite 4-hydroxytamoxifen are selective estrogen response mo difiers (SERMs) that act as estrogen antagonists in mammary gland. Blocks estradiol-stimulated VEGF production in breast tumor cells.

See more products at: